The decreasing impact on the Alzheimer’s disease risk correlates with its inhibition effects against the acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) (Ozturk et al., 2014). Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.